Just over five years ago, the FDA approved the first comprehensive NextGeneration Sequencing tests. 

This test takes a pieces of a person’s actual tumor and analyzes the genetic mutations. When we talk of personalized treatment, this is it. 

We believe all high-risk cancer patients should get NextGeneration tumor sequencing.

In this webinar, we discuss what makes a patient high-risk, what the test does for patients, and how to get it.

‍

You may know the test by other names:

- Genetic Analysis

- Molecular Profiling

- Tumor Sequencing

- Biomarker Testing

- Genomic Testing

- Next Generation (NextGen) Sequencing

‍

Essentially they are all the same in that they look at the DNA makeup of a patient's cancer. And for nearly every patient, this is different and can guide them to the best cancer care possible.

‍

CHAPTERS

‍0:00 Introduction

‍0:37 What is the one test that every single cancer patient should know?

‍4:27 What are gene mutations like BRAC?

‍6:04 What makes it NextGen sequencing?

‍8:01 Who should get NextGen sequencing?

‍11:53 How do you get NextGen sequencing done and get the report?

‍14:10 How Does this affect treatment decisions?

‍15:34 How else is tumor sequencing helpful to cancer patients?

‍18:04 Why aren’t more cancer patients getting this test done?

‍19:23 When and how do you ask your oncologist about this?

23:47 What to do if no tumor tissue is available (circulating tumor DNA test)

‍25:17 What to do if your oncologist won’t order the test?

‍26:28 What test is best (any that test as much as possible)?

‍27:55 Why my oncologist tells me that the report won’t change my treatment?

‍29:09 Matching to clinical trials from NextGen sequencing.

‍